Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Miao He und 18 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Tropical Disease Control, Centre for Infection and Immunity Studies, School of Medicine, Shenzhen Campus of Sun Yat-sen Univers…. Hauptthemen laut MEDLINE: Methyltransferases, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Cap RNA methylations play important roles in the replication, evasion of host RNA sensor recognition, and pathogenesis. Coronaviruses possess both guanine N7‐ and 2′‐O‐ribose methyltransferases (N7‐MTase and 2′‐O‐MTase) encoded by nonstructural protein (nsp) 14 and nsp16/10 complex, respectively. In this study, we reconstituted the two‐step RNA methylations of N7‐MTase and 2′‐O‐MTase of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in vitro and demonstrated its common and different features in comparison with that of SARS‐CoV. We revealed that the nsp16/10 2′‐O‐MTase of SARS‐CoV‐2 has a broader substrate selectivity than the counterpart of SARS‐CoV and can accommodate both unmethylated and uncapped RNA substrates in a sequence‐independent manner. Most intriguingly, the substrate selectivity of nsp16/10 complex is not determined by the apoenzyme of nsp16 MTase but by its cofactor nsp10. These results provide insight into the unique features of SARS‐CoV‐2 MTases and may help develop strategies to precisely intervene in the methylation pathway and pathogenesis of SARS‐CoV‐2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Tropical Disease Control, Centre for Infection and Immunity Studies, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China.
- Guangzhou Laboratory, Guangzhou International Bio-Island, Guangzhou, Guangdong, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
ORCID-Profile: Luyang Xie
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- National Key Research and Development Program of China
- "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project of Guangdong Province
Zitieren
APA
He, M., Cao, L., Liu, L., Jin, X., Zheng, B., Liu, X., Zhuang, J., Zhang, F., Yang, Z., Ji, Y., Xu, T., Huang, S., Chen, J., Xie, L., Li, K., Hou, P., Pan, J., Guo, D., & Li, C. (2024). Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases. Journal of Medical Virology. https://doi.org/10.1002/jmv.29411
Vancouver
He M, Cao L, Liu L, Jin X, Zheng B, Liu X, et al. Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases. Journal of Medical Virology. 2024. doi:10.1002/jmv.29411
BibTeX
@article{He2024,
author = {He, Miao and Cao, Liu and Liu, Lihong and Jin, Xu and Zheng, Birong and Liu, Xue and Zhuang, Jiaxin and Zhang, Fushi and Yang, Zixiao and Ji, Yanxi and Xu, Tiefeng and Huang, Siyao and Chen, Junhai and Xie, Luyang and Li, Kun and Hou, Panpan and Pan, Jian and Guo, Deyin and Li, Chunmei},
title = {Reconstitution of RNA cap methylation reveals different features of SARS‐CoV‐2 and SARS‐CoV methyltransferases},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29411}
}
EUVIMED